How much will Herceptin really cost?

Ann Barrett ; Tom Roques ; Matthew Small ; Richard D Smith ; (2006) How much will Herceptin really cost? BMJ, 333 (7578). pp. 1118-1120. ISSN 1468-5833 DOI: 10.1136/bmj.39008.624051.BE
Copy

New guidance from the National Institute for Health and Clinical Excellence recommends Herceptin in early breast cancer, but it provides no additional funding or any suggestion of which services to cut. This leaves medical staff with difficult decisions to make
Item Type Article
Keywords Antibodies, Monoclonal, economics, therapeutic use, Antineoplastic Agents, economics, therapeutic use, Breast Neoplasms, drug therapy, economics, Chemotherapy, Adjuvant, economics, Cost-Benefit Analysis, Drug Costs, Female, Humans
ISI 242520200021
Date Deposited 17 Oct 2011 17:58

Explore Further

picture_as_pdf
1118.full.pdf
subject
Published Version
Available under Creative Commons: Attribution-NonCommercial 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads